Tech Company Financing Transactions
Perthera Funding Round
On 1/8/2019, Perthera landed $2.1 million in funding from private investors.
Transaction Overview
Company Name
Announced On
1/8/2019
Transaction Type
Debt
Amount
$2,100,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. 1 investor participated in the offering. The amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt. SEC regulatory filing.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
8200 Greensboro Dr. 350
McLean, VA 22102
USA
McLean, VA 22102
USA
Phone
Website
Email Address
Overview
Perthera is the only personalized medicine firm to use state-of-the-art diagnostic tools and the most comprehensive multi-omic molecular profiling available, enabling oncologists to deliver precision, personalized medicine in the treatment of a patient's unique cancer.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Gary Gregory
Chief Medical Officer
Michael Pishvaian
Chief Scientific Officer
Emanuel Petricoin
VP - Bus. Development
Matthew Meyer
VP - Engineering
Sam Leslie
VP - Marketing
Philip Robertson
VP - Operations
Kimberly Mason
Browse more venture capital transactions:
Prev: 1/8/2019: StructionSite venture capital transaction
Next: 1/8/2019: Tidelift venture capital transaction
Share this article
About Database of VC Transactions
We do our best to report on every notable VC transaction. All VC database entries on this site are derived from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs